Poseida Therapeutics Appoints Debra Gessner as Vice President, Regulatory Affairs

Poseida Therapeutics Inc., a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, today announced that Debra Gessner has joined the company as vice president, regulatory affairs.